Dec.16, 2025 — Three international nuclear medicine organizations — the SNMMI Clinical Trials Network (SNMMI-CTN), the Australasian Radiopharmaceutical Trials Network (ARTnet) and the European Association of Nuclear Medicine Forschungs GmbH (EARL) — have jointly endorsed a unified PET/CT and PET/MR scanner accreditation framework to standardize and harmonize quantitative PET imaging worldwide.

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new data that highlights how the company’s advanced AI-powered mammography solution can aid in detecting more breast cancers.

Dec. 11, 2025 — Healthcare Administrative Partners (HAP), a provider of outsourced billing, coding and practice management solutions for radiology practices, has announced the addition of Summit Radiology in Fort Wayne, Indiana, to its roster of revenue cycle management clients. Summit Radiology is the largest full-service diagnostic and interventional radiology group in the region, providing services at over 40 outpatient and hospital locations in northeast and central Indiana.

Dec. 12, 2025 — Hyperfine, Inc. has announced that it has received FDA clearance for a new multi-direction diffusion-weighted imaging (DWI) software sequence. This advancement delivers substantially improved image quality and diagnostic confidence for stroke detection, marking a significant expansion of the Swoop® system's clinical capabilities in acute neurological care.

Dec. 11. 2025 —  A new study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were treated with proton therapy (IMPT) compared to those treated with traditional radiation therapy (IMRT). The study, led by researchers at the University of Texas MD Anderson Cancer Center, is the first to demonstrate a survival benefit for proton therapy.

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens Healthineers company, to develop novel clinical applications that combine Telix's theranostic products and external beam radiation therapy (EBRT).

Dec. 9, 2025 — NVision Imaging Technologies, developer of quantum technology enabling imaging of cell metabolism through MRIs, announced that Memorial Sloan Kettering Cancer Center (MSK) is using its device, Polaris, in oncological preclinical studies. This marks the first use of NVision’s technology at a leading cancer research institution to monitor treatment efficacy in targeted therapies.

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have released Pillar (Pillar-0), an open-source AI model that analyzes medical images and recognizes conditions with an unprecedented degree of diagnostic accuracy. Unlike existing tools that are limited to a handful of conditions or models primarily designed for 2D images, Pillar-0 interprets 3D volumes directly and can recognize hundreds of conditions from a single CT or MRI exam.

Dec. 5, 2025 — Virtual Phantoms Inc. has launched VirtualDose DX — the company’s latest innovation in radiation dose estimation, now applied to diagnostic radiography. VPI has developed industry leading software products VirtualDoseCT for CT and VirtualDoseIR for interventional radiology dose estimation. VirtualDoseDX leverages the same validated Monte Carlo–based technology, extending our dose estimation expertise to radiographic (X-ray) exams.

Nov. 30, 2025 – Ascend Cardiovascular, a provider of purpose-built enterprise imaging for cardiology, and Konica Minolta Healthcare Americas, Inc., a provider of medical diagnostic imaging and healthcare IT solutions, have announced a strategic partnership to deliver a unified and complete enterprise imaging solution for hospital cardiology departments and cardiology practices.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now